BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8403225)

  • 1. Differential inhibition of the DNA binding of transcription factors NF kappa B and OTF-1 by nitrogen mustard and quinacrine mustard: transcriptional implications.
    Fabbri S; Prontera C; Broggini M; D'Incalci M
    Carcinogenesis; 1993 Sep; 14(9):1963-7. PubMed ID: 8403225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
    Burysek L; Yeow WS; Pitha PM
    J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE; Khalili K; Amini S
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential sensitivity of transcription factors to mustard-damaged DNA.
    Chen XM; Gray PJ; Cullinane C; Phillips DR
    Chem Biol Interact; 1999 Mar; 118(1):51-67. PubMed ID: 10227578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid can reduce the transcriptional activation of HIV-1 promoter through the reduction of active NF-kappaB.
    Kurata Si; Yamamoto N
    J Cell Biochem; 1999 Nov; 76(1):13-9. PubMed ID: 10580996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of octamer-containing promoters by either octamer-binding transcription factor 1 (OTF-1) or OTF-2 and requirement of an additional B-cell-specific component for optimal transcription of immunoglobulin promoters.
    Pierani A; Heguy A; Fujii H; Roeder RG
    Mol Cell Biol; 1990 Dec; 10(12):6204-15. PubMed ID: 2123291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the human immunodeficiency virus type 1 long terminal repeat by BTEB, a GC box-binding transcription factor.
    Imataka H; Mizuno A; Fujii-Kuriyama Y; Hayami M
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):825-31. PubMed ID: 8257632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conserved high-affinity NF-kappa B binding site in the interferon regulatory factor-1 promoter is not occupied by NF-kappa B in vivo and is transcriptionally inactive.
    Rein T; Schreck R; Willenbrink W; Neubert WJ; Zorbas H; Bäuerle PA
    J Inflamm; 1995; 45(4):269-82. PubMed ID: 8867671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene.
    Lavrovsky Y; Schwartzman ML; Levere RD; Kappas A; Abraham NG
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5987-91. PubMed ID: 8016102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
    Zhang JL; Sharma PL; Crumpacker CS
    Virology; 2000 Mar; 268(2):251-63. PubMed ID: 10704334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NF-kappa B p65 promoter.
    Ueberla K; Lu Y; Chung E; Haseltine WA
    J Acquir Immune Defic Syndr (1988); 1993 Mar; 6(3):227-30. PubMed ID: 8450395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative effects of C/EBP-like and NF kappa B-like binding sites on rat serum amyloid A1 gene expression in liver cells.
    Li X; Liao WS
    Nucleic Acids Res; 1992 Sep; 20(18):4765-72. PubMed ID: 1408789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of DNA lesion formation and removal following treatment of L1210 cells with nitrogen mustards.
    O'Connor PM; Kohn KW
    Cancer Commun; 1990; 2(12):387-94. PubMed ID: 2265064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
    Wright KL; Ting JP
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor OTF-1 interacts with two distinct DNA elements in the A gamma-globin gene promoter.
    Ponce E; Lloyd JA; Pierani A; Roeder RG; Lingrel JB
    Biochemistry; 1991 Mar; 30(11):2961-7. PubMed ID: 2007132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
    Härtig E; Cato AC
    Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionizing radiation activates nuclear factor kappa B but fails to produce an increase in human immunodeficiency virus gene expression in stably transfected human cells.
    Valerie K; Laster WS; Kirkham JC; Kuemmerle NB
    Biochemistry; 1995 Dec; 34(48):15768-76. PubMed ID: 7495808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.
    Duyao MP; Buckler AJ; Sonenshein GE
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4727-31. PubMed ID: 2191300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a high affinity octamer transcription factor binding site in the human lipoprotein lipase promoter.
    Currie RA; Eckel RH
    Arch Biochem Biophys; 1992 Nov; 298(2):630-9. PubMed ID: 1416992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.